{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:49:40Z","timestamp":1792680580022,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Tuberculosis (TB) remains a significant global health concern. Accurate detection of latent TB infection is crucial for effective control and prevention. We aimed to assess the performance of an interferon-gamma release assay blood test (QuantiFERON-TB Gold Plus [QFT-Plus]) in various clinical contexts and identify conditions that affect its results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective analysis of 31 000 QFT-Plus samples collected from 26 000 subjects at a tertiary hospital in South Korea over a 4-year period and compared the rates of positivity and indeterminate results across diverse clinical situations. We also analysed the contribution of the QuantiFERON TB2 tube to the test\u2019s sensitivity and determined optimal cutoff values for 3 hematologic parameters to distinguish false-negative results. These cutoff values were validated in a separate cohort of subjects with microbiologically confirmed subclinical TB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Rates of QFT-Plus positivity and indeterminate results were disparate across diagnoses. The TB2 tube increased QFT-Plus sensitivity by 4.1% (95% CI, 1.1%\u20137.0%) in patients with subclinical TB. Absolute lymphocyte count \u22641.19 \u00d7 109\/L, absolute neutrophil count \u22655.88 \u00d7 109\/L, and neutrophil-to-lymphocyte ratio \u22654.33 were effective criteria to discriminate false-negative QFT-Plus results. Application of the hematologic criteria, individually or combined with mitogen response &amp;lt;10\u2005IU\/mL, substantially improved performance in the main study cohort and the validation cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings highlight the influence of clinical context and patient hematologic profiles on QFT-Plus results. To minimise neglected latent TB infections due to false-negative QFT-Plus results, serial retesting is advisable in patients with severe lymphopenia or neutrophilia, particularly when the mitogen response is &amp;lt;10\u2005IU\/mL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/clinchem\/hvad220","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T14:14:01Z","timestamp":1706796841000},"page":"551-561","source":"Crossref","is-referenced-by-count":6,"title":["A Retrospective Study of Factors Contributing to the Performance of an Interferon-Gamma Release Assay Blood Test for Tuberculosis Infection"],"prefix":"10.1093","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-1942","authenticated-orcid":false,"given":"Junhyup","family":"Song","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine , Seoul 03722 , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2609-8945","authenticated-orcid":false,"given":"Sinyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine , Seoul 03722 , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8458-1495","authenticated-orcid":false,"given":"Younhee","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine , Seoul 03722 , Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"2024030223244566000_hvad220-B1","doi-asserted-by":"crossref","DOI":"10.1128\/9781555819866","volume-title":"Tuberculosis and nontuberculous mycobacterial infections","author":"Schlossberg","year":"2017"},{"key":"2024030223244566000_hvad220-B2","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ijid.2022.03.011","article-title":"The WHO global tuberculosis 2021 report\u2014not so good news and turning the tide back to end TB","volume":"124","author":"Jeremiah","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2024030223244566000_hvad220-B3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"2024030223244566000_hvad220-B4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5588\/ijtld.17.0721","article-title":"Multicenter study of quantiferon(\u00ae)-tb gold plus in patients with active tuberculosis","volume":"22","author":"Horne","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024030223244566000_hvad220-B5","doi-asserted-by":"crossref","first-page":"e0187021","DOI":"10.1128\/spectrum.01870-21","article-title":"Comparison of quantiferon-tb gold in-tube and quantiferon-tb gold-plus in the diagnosis of mycobacterium tuberculosis infections in immunocompromised patients: a real-world study","volume":"10","author":"Xu","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2024030223244566000_hvad220-B6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","article-title":"First characterization of the CD4 and CD8 T-cell responses to quantiFERON-TB plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J Infect"},{"key":"2024030223244566000_hvad220-B7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jiac.2020.01.011","article-title":"Role of CD8 T-cell in immune response to tuberculosis-specific antigen in quantiFERON-TB Gold Plus","volume":"26","author":"Tsuyuzaki","year":"2020","journal-title":"J Infect Chemother"},{"key":"2024030223244566000_hvad220-B8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2019.01.007","article-title":"Cd8 response measured by quantiFERON-TB Gold Plus and tuberculosis disease status","volume":"78","author":"Lee","year":"2019","journal-title":"J Infect"},{"key":"2024030223244566000_hvad220-B9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/tropicalmed7100278","article-title":"Factors influencing false-negative results of quantiFERON-TB Gold in-tube (QFT-GIT) in active tuberculosis and the desirability of resetting cutoffs for different populations: a retrospective study","volume":"7","author":"Yu","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"2024030223244566000_hvad220-B10","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211028437","article-title":"Features of indeterminate results of quantiFERON-TB Gold in-tube test in patients with haematological malignancies","volume":"12","author":"Huang","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"2024030223244566000_hvad220-B11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10096-019-03768-9","article-title":"Clinical application of quantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis","volume":"39","author":"Chen","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024030223244566000_hvad220-B12","doi-asserted-by":"crossref","first-page":"e13087","DOI":"10.1111\/tid.13087","article-title":"High rates of indeterminate interferon-gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates","volume":"21","author":"Wigg","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"2024030223244566000_hvad220-B13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/rheumatology\/kez390","article-title":"High rate of indeterminate results of the quantiferon-tb gold in-tube test, third generation, in patients with systemic vasculitis","volume":"59","author":"Rousset","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2024030223244566000_hvad220-B14","doi-asserted-by":"crossref","first-page":"e0187313","DOI":"10.1371\/journal.pone.0187313","article-title":"A borderline range for quantiFERON Gold in-tube results","volume":"12","author":"Jonsson","year":"2017","journal-title":"PLoS One"},{"key":"2024030223244566000_hvad220-B15","doi-asserted-by":"crossref","first-page":"e0137021","DOI":"10.1128\/JCM.01370-21","article-title":"The impact of borderline quantiFERON-TB Gold Plus results for latent tuberculosis screening under routine conditions in a low-endemicity setting","volume":"59","author":"Wikell","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2024030223244566000_hvad220-B16","doi-asserted-by":"crossref","first-page":"e00272-20","DOI":"10.1128\/JCM.00272-20","article-title":"Accuracy of quantiFERON-TB Gold Plus test for diagnosis of mycobacterium tuberculosis infection in children","volume":"58","author":"Buonsenso","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2024030223244566000_hvad220-B17","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1093\/cid\/ciaa1822","article-title":"Comparing the diagnostic performance of quantiFERON-TB Gold Plus to other tests of latent tuberculosis infection: a systematic review and meta-analysis","volume":"73","author":"Oh","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024030223244566000_hvad220-B18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"Quantiferon TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu","year":"2019","journal-title":"J Infect"},{"key":"2024030223244566000_hvad220-B19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cmi.2016.05.006","article-title":"Equal sensitivity of the new generation quantiFERON-TB Gold Plus in direct comparison with the previous test version quantiFERON-TB Gold IT","volume":"22","author":"Hoffmann","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2024030223244566000_hvad220-B20","doi-asserted-by":"crossref","first-page":"e0141421","DOI":"10.1128\/JCM.01414-21","article-title":"Elevated rates of indeterminate results on quantiFERON-TB Gold Plus in COVID-19 patients","volume":"59","author":"Shier","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2024030223244566000_hvad220-B21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0961203310397966","article-title":"Interferon-gamma release assay for diagnosing mycobacterium tuberculosis infections in patients with systemic lupus erythematosus","volume":"20","author":"Takeda","year":"2011","journal-title":"Lupus"},{"key":"2024030223244566000_hvad220-B22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tube.2007.01.002","article-title":"Plasma granulysin levels and cellular interferon-gamma production correlate with curative host responses in tuberculosis, while plasma interferon-gamma levels correlate with tuberculosis disease activity in adults","volume":"87","author":"Sahiratmadja","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"2024030223244566000_hvad220-B23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2022.05.028","article-title":"Indeterminate results of quantiFERON-TB Gold in-tube due to high nil concentration and methodological exploration and improvement","volume":"533","author":"Peng","year":"2022","journal-title":"Clin Chim Acta"},{"key":"2024030223244566000_hvad220-B24","doi-asserted-by":"crossref","first-page":"e0081121","DOI":"10.1128\/JCM.00811-21","article-title":"Indeterminate quantiFERON Gold Plus results reveal deficient interferon gamma responses in severely ill COVID-19 patients","volume":"59","author":"Ward","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2024030223244566000_hvad220-B25","doi-asserted-by":"crossref","first-page":"e0185822","DOI":"10.1128\/spectrum.01858-22","article-title":"Longitudinal evaluation of the quantiFERON-TB Gold Plus assay in hospitalized COVID-19 patients with a first indeterminate result: resolution of inflammation and restoration of T-lymphocyte counts and interferon-gamma production","volume":"10","author":"Alessio","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2024030223244566000_hvad220-B26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/jcm10050918","article-title":"Clinical significance of indeterminate quantiFERON-TB Gold Plus assay results in hospitalized COVID-19 patients with severe hyperinflammatory syndrome","volume":"10","author":"Solanich","year":"2021","journal-title":"J Clin Med"},{"key":"2024030223244566000_hvad220-B27","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/S1473-3099(22)00227-4","article-title":"Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia","volume":"22","author":"Bergeron","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2024030223244566000_hvad220-B28","doi-asserted-by":"crossref","first-page":"e01950","DOI":"10.1128\/JCM.01950-19","article-title":"Fourth-generation quantiFERON-TB Gold Plus: what is the evidence?","volume":"58","author":"Shafeque","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2024030223244566000_hvad220-B29","doi-asserted-by":"crossref","first-page":"15626","DOI":"10.1038\/s41598-018-33825-w","article-title":"Effect of therapy on quantiFERON-Plus response in patients with active and latent tuberculosis infection","volume":"8","author":"Petruccioli","year":"2018","journal-title":"Sci Rep"},{"key":"2024030223244566000_hvad220-B30","doi-asserted-by":"crossref","first-page":"1601976","DOI":"10.1183\/13993003.01976-2016","article-title":"QuantiFERON-TB(\u00ae) Gold Plus as a potential tuberculosis treatment monitoring tool","volume":"49","author":"Kamada","year":"2017","journal-title":"Eur Respir J"},{"key":"2024030223244566000_hvad220-B31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2012.11.023","article-title":"Antigen-specific CD4- and CD8-positive signatures in different phases of mycobacterium tuberculosis infection","volume":"75","author":"Nikolova","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2024030223244566000_hvad220-B32","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of quantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"2024030223244566000_hvad220-B33","doi-asserted-by":"crossref","first-page":"e0097221","DOI":"10.1128\/Spectrum.00972-21","article-title":"Identification of recent tuberculosis exposure using quantiFERON-TB Gold Plus, a multicenter study","volume":"9","author":"P\u00e9rez-Recio","year":"2021","journal-title":"Microbiol Spectr"},{"key":"2024030223244566000_hvad220-B34","first-page":"1568","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease","volume":"43","author":"Rozot","year":"2013","journal-title":"Eur Respir J"},{"key":"2024030223244566000_hvad220-B35","doi-asserted-by":"crossref","first-page":"825021","DOI":"10.3389\/fmicb.2022.825021","article-title":"QuantiFERON-TB Gold Plus assay in patients with latent vs. active tuberculosis in a low incidence setting: level of IFN-\u03b3, CD4\/CD8 responses, and release of IL-2, IP-10, and MIG","volume":"13","author":"Carr\u00e8re-Kremer","year":"2022","journal-title":"Front Microbiol"},{"key":"2024030223244566000_hvad220-B36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-\u03b3 release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"2024030223244566000_hvad220-B37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-\u03b3 release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur Respir J"},{"key":"2024030223244566000_hvad220-B38","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2024030223244566000_hvad220-B39","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.3390\/jcm10194357","article-title":"Frequency and factors of indeterminate quantiFERON-TB Gold in-tube and quantiFERON-TB Gold Plus test results in rheumatic diseases","volume":"10","author":"Ahn","year":"2021","journal-title":"J Clin Med"},{"key":"2024030223244566000_hvad220-B40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jiac.2017.09.012","article-title":"Lymphocyte subset analysis in quantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis","volume":"24","author":"Igari","year":"2018","journal-title":"J Infect Chemother"},{"key":"2024030223244566000_hvad220-B41","doi-asserted-by":"crossref","first-page":"e0125794","DOI":"10.1371\/journal.pone.0125794","article-title":"Neutrophil-to-lymphocyte ratio is associated with impaired interferon-gamma release to phytohemagglutinin","volume":"10","author":"Woo","year":"2015","journal-title":"PLoS One"},{"key":"2024030223244566000_hvad220-B42","doi-asserted-by":"crossref","first-page":"876864","DOI":"10.3389\/fmed.2022.876864","article-title":"Beyond quantiFERON-TB results, the added value of a weak mitogen response","volume":"9","author":"Jacquier","year":"2022","journal-title":"Front Med"},{"key":"2024030223244566000_hvad220-B43","doi-asserted-by":"crossref","first-page":"1602102","DOI":"10.1183\/13993003.02102-2016","article-title":"Quantiferon test interpretation in patients receiving immunosuppressive agents: an alert","volume":"49","author":"Belliere","year":"2017","journal-title":"Eur Respir J"},{"key":"2024030223244566000_hvad220-B44","doi-asserted-by":"crossref","first-page":"e0029523","DOI":"10.1128\/jcm.00295-23","article-title":"Inflated gamma interferon response with quantiFERON-TB Gold Plus using the automated liaison XL analyzer: a testing algorithm to mitigate false-positive results in low-incidence settings","volume":"61","author":"Buron","year":"2023","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/70\/3\/551\/56822313\/hvad220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/70\/3\/551\/56822313\/hvad220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T23:25:03Z","timestamp":1709421903000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/70\/3\/551\/7595825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2,1]]},"published-print":{"date-parts":[[2024,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvad220","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2024,2,1]]}}}